pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea
BACKGROUND: Pyrazinamide (PZA) is among the first-line drugs for the treatment of tuberculosis. In vitro, it kills semidormant mycobacteria only at low pH. The purpose of this study was to compare PZA resistance with pyrazinamidase (PZase) activity and the genotype to better understand the molecular...
Sábháilte in:
| Foilsithe in: | BMC Infect Dis |
|---|---|
| Príomhchruthaitheoirí: | , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMC
2001
|
| Ábhair: | |
| Rochtain ar líne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC33507/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11429043/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2334-1-4 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|